|
Using a clinicopathologic and gene expression model to identify melanoma patients at high risk for disease relapse. |
|
|
Stock and Other Ownership Interests - RiverD; Skyline Diagnostics; Theranovir |
Honoraria - BIOCAD; BIOINVENT; Bristol-Myers Squibb; CatalYm; Ellipses Pharma; GlaxoSmithKline; iOMEDICO; ISA Pharmaceuticals; MSD; NEKTAR; Novartis; Pfizer; Sanofi; Sellas Life Sciences; Skyline Diagnostics |
Consulting or Advisory Role - BIOINVENT; Bristol-Myers Squibb; CatalYm; Ellipses Pharma; GlaxoSmithKline; Incyte; iOMEDICO; ISA Pharmaceuticals; MSD; NEKTAR; Novartis; Pfizer; Sanofi; Sellas Life Sciences; Skyline Diagnostics |
|
Expert Testimony - Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Employment - Skyline Diagnostics |
Stock and Other Ownership Interests - Skyline Diagnostics; Synlogic |
Patents, Royalties, Other Intellectual Property - Gene signatures for predicting metastasis of melanoma |
|
|
Employment - Skyline Diagnostics |
Stock and Other Ownership Interests - Skyline Diagnostics |
|
|
Employment - Skyline Diagnostics |
|
|
No Relationships to Disclose |
|
Sindhuja Sominidi Damodaran |
No Relationships to Disclose |
|
|
Employment - Skyline Diagnostics |
Stock and Other Ownership Interests - Skyline Diagnostics |
Patents, Royalties, Other Intellectual Property - Named inventor on patents in the Multiple Myeloma field. |
|
|
No Relationships to Disclose |
|
|
Research Funding - Skyline Diagnostics (Inst) |
Patents, Royalties, Other Intellectual Property - Mayo Clinic has filed several patent applications on which I am listed as an inventor. Technologies are in the area of wound healing and skin cancer. (Inst) |